Evidence map›Paper›PMID 40352673›Full record

ReviewRSC medicinal chemistry2025

Chromenochalcones: a comprehensive review on developments towards a medicinal perspective.

Rohit Singh, Archita Katrolia, Ved Pal

Abstract readReview
In one paragraph

Review in RSC medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Reusable Pd/TiOMolecular diversity · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rohit SinghDepartment of Pharmaceutical Chemistry, College of Pharmacy, JSS University C-1/A, Sector-62 Noida Uttar Pradesh India drrohitsingh.lko@gmail.com.ORCID https://orcid.org/0000-0001-8542-6534
Archita KatroliaDepartment of Pharmaceutics, College of Pharmacy, JSS University C-1/A, Sector-62 Noida Uttar Pradesh India architakatrolia95@gmail.com.ORCID https://orcid.org/0000-0002-2958-0964
Ved PalDepartment of Pharmacognosy, College of Pharmacy, JSS University C-1/A, Sector-62 Noida Uttar Pradesh India vedpal@jssaten.ac.in.ORCID https://orcid.org/0000-0003-3523-1469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chalcones are indeed a versatile scaffold in medicinal chemistry. Their structure, featuring an α,β-unsaturated carbonyl group, makes them highly reactive and capable of interacting with various biological targets. This reactivity is a key reason why chalcones and their derivatives are of such interest in drug discovery. The continued exploration of chalcone derivatives in medicinal chemistry will likely yield new insights and therapeutic candidates, given their broad spectrum of biological activities and the flexibility in modifying their structures. As chalcone derivatives, pyranochalcones and chromanchalcones are members of a subclass of flavonoids that are widely distributed. Several scientific databases were investigated to compile articles that illustrated the biological functions of chromenochalcones and their derivatives. Preclinical research on chromenochalcones and their derivatives is well covered in this review, highlighting the compounds with enormous significance as antimalarial, anti-inflammatory, antileishmanial, cytotoxic, antibacterial, antifungal, and antioxidant agents. In addition, the article briefly discusses the synthetic pathways employed for the total synthesis of selected pyranochalcones, including mallaophilippens C and E, citrunobin, and lesperol. Consequently, this overview may help research and design novel, potent therapeutic medications based on previously developed methodologies. This review is intended to provide a thorough, authoritative, and critical assessment of the chromenochalcone template for the chemistry community.

Identifiers

PMID40352673
PMCPMC12062893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.